CN108676308A - A kind of preparation method of medical non-toxic plastic - Google Patents

A kind of preparation method of medical non-toxic plastic Download PDF

Info

Publication number
CN108676308A
CN108676308A CN201810546474.4A CN201810546474A CN108676308A CN 108676308 A CN108676308 A CN 108676308A CN 201810546474 A CN201810546474 A CN 201810546474A CN 108676308 A CN108676308 A CN 108676308A
Authority
CN
China
Prior art keywords
parts
preparation
antioxidant
rate
fergusonite
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201810546474.4A
Other languages
Chinese (zh)
Inventor
吕少波
李卓才
李苏杨
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suzhou Jonathan New Materials Technology Co Ltd
Original Assignee
Suzhou Jonathan New Materials Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suzhou Jonathan New Materials Technology Co Ltd filed Critical Suzhou Jonathan New Materials Technology Co Ltd
Priority to CN201810546474.4A priority Critical patent/CN108676308A/en
Publication of CN108676308A publication Critical patent/CN108676308A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L51/00Compositions of graft polymers in which the grafted component is obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers
    • C08L51/02Compositions of graft polymers in which the grafted component is obtained by reactions only involving carbon-to-carbon unsaturated bonds; Compositions of derivatives of such polymers grafted on to polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/025Other specific inorganic materials not covered by A61L27/04 - A61L27/12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/20Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/24Materials or treatment for tissue regeneration for joint reconstruction
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00Use of inorganic substances as compounding ingredients
    • C08K3/02Elements
    • C08K3/08Metals
    • C08K2003/0806Silver
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00Use of inorganic substances as compounding ingredients
    • C08K3/18Oxygen-containing compounds, e.g. metal carbonyls
    • C08K3/20Oxides; Hydroxides
    • C08K3/22Oxides; Hydroxides of metals
    • C08K2003/2237Oxides; Hydroxides of metals of titanium
    • C08K2003/2241Titanium dioxide
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00Use of inorganic substances as compounding ingredients
    • C08K3/18Oxygen-containing compounds, e.g. metal carbonyls
    • C08K3/20Oxides; Hydroxides
    • C08K3/22Oxides; Hydroxides of metals
    • C08K2003/2296Oxides; Hydroxides of metals of zinc
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K2201/00Specific properties of additives
    • C08K2201/011Nanostructured additives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Materials For Medical Uses (AREA)

Abstract

The invention discloses a kind of preparation method of medical non-toxic plastic, raw material is:EBS, zinc oxide, calcined kaolin, Ag-carried nanometer titanium dioxide, Graft Copolymerization of MMA onto Chitosan, cellulose acetate-butyrate, dioctyltin thioglycol monooctyl ester, deca-BDE, acetylene carbon black, antimony oxide, land plaster, fergusonite powder, kaolin, manganese naphthenate, ultra-violet absorber UV P and antioxidant;Longitudinal 40 50MPa of product tensile strength, laterally 10 30MPa, hardness are good;Escherichia coli antibiotic rate 99 99.5%, staphylococcus aureus antibiotic rate 98 99%, Pseudomonas aeruginosa bacteriostasis rate 99.5 99.9%, salmonella typhimurium bacteriostasis rate 93 97%, Friedlander's bacillus bacteriostasis rate 92 96%, hay bacillus sterilization rate 94 98%, sarcine sterilization rate 91 95%.

Description

A kind of preparation method of medical non-toxic plastic
Technical field
The present invention relates to medical material tech field more particularly to a kind of preparation methods of medical non-toxic plastic.
Background technology
Ethylene bis stearamide(Vinyl bis-stearamides)One hard and crisp white high melting-point wax, industrial goods are in slightly The fine particle of yellow, it is nontoxic, it is without side-effects to human body, most of solvents are not dissolved under room temperature, and soda acid and aqueous medium are stablized, The chlorinated hydrocarbons and aromatic hydrocarbon solvent of heat can be dissolved in, powder soapy feeling is stronger, and 80 DEG C or more to water with wettable Compound.
There is good compatibility between this kind of material and intravenous fluid and blood, thus is widely used, it is such as each Kind flexible pipe for medical purpose, blood storage device, dialysis attachment, surgical glove, medical condition and man-made organ etc..
Oral administration solid and liquid, medicinal plastic bottle belong to a kind of packaging material.Not cleaned and sterilizing can be used to Key works Drug packing, because This, has higher requirements to microbial limit, and production environment and production process should meet the requirement of relevant laws and regulations.
Medical plastic one is to take for the purpose of improving yield and improve the methods of speed, a tractor serves several purposes;Second is that increasing waste and old Plastic recoverying equipment(It is various crusher types, complete in specifications, absolutely prove technics of reclaim of plastic waste using being paid attention to extensively);Third, Secondary operation equipment and processing technology are developed, new application is opened up.After implementing international environment standard IS014000 in 1996, protect Retaining ring border, maintaining ecological balance also become countries in the world and pack.
In many thermoplasticity and thermosetting plastics be used as inside and outside lubrication prescription, most representative such as ABS, PS, AS, PVC is equally applicable for PE, PP, PVAC, cellulose acetate(cellulose,Acctate), nylon (Nylon), phenolic resin (pheonolic-Resin), aminoplast etc., there is good finish, demoulding.
In thermoplastic PUR injection moldings, which has also acted as internal remover, and additive amount is 0.1 ~ 1%.
As polyformaldehyde lubricant, additive amount 0.5% improves melt flow rate (MFR), improves demoulding, and poly- first Whiteness, thermal stability and the every physical index of aldehyde reach top grade product index, design a kind of medical poisonless that bacteriostasis rate is good modeling Material is very important.
Invention content
The application in view of the above technical problems, provides a kind of preparation method of medical non-toxic plastic, solves existing medical material Expect Escherichia coli antibiotic rates, staphylococcus aureus antibiotic rate, hay bacillus sterilization rate and the technical problems such as mechanical property is low.
The present invention uses following technical scheme:A kind of preparation method of medical non-toxic plastic, includes the following steps:
The first step:EBS100 parts are weighed according to mass fraction proportioning, 5-15 parts of zinc oxide, 1-5 parts of calcined kaolin, silver-carrying nano 4-8 parts of titanium dioxide, 1-3 parts of Graft Copolymerization of MMA onto Chitosan, 2-4 parts of cellulose acetate-butyrate, dioctyltin sulphur 2-6 parts of glycol monooctyl ester, 3-5 parts of deca-BDE, 0.5-2.5 parts of acetylene carbon black, 8-10 parts of antimony oxide, 3-7 parts of land plaster, 4-6 parts of fergusonite powder, 5-9 parts of kaolin, 5-7 parts of manganese naphthenate, 0.5-1.5 parts of Ultraviolet Absorber UV-P, antioxidant 2.5-4.5 part;
Second step:EBS, zinc oxide, land plaster, fergusonite powder and manganese naphthenate are put into reaction kettle and are heated to 60-80 DEG C, Stir 30-50min, 300-500 revs/min of mixing speed;
Third walks:Then add the remaining raw materials are warming up to 100-120 DEG C, stir 40-60min, 200-600 revs/min of mixing speed Clock;
4th step:By mixed material put into extruder in, 180-190 DEG C of barrel temperature, 195-205 DEG C, 200-210 DEG C, 205-215 DEG C, 220-230 DEG C, 235-245 DEG C and 240-260 DEG C, screw rod 40-50mm, L/D 20-25, screw speed 60-80 Rev/min, squeeze out yield 30-40kg/h, 230-250 DEG C of head temperature.
As a preferred technical solution of the present invention:The raw material of the preparation method of the medical non-toxic plastic presses mass parts Number proportioning is as follows:EBS100 parts, 1 part of zinc oxide, 5 parts of calcined kaolin, 3 parts of Ag-carried nanometer titanium dioxide, chitosan graft first 5 parts of base methyl acrylate, 2 parts of cellulose acetate-butyrate, 10 parts of dioctyltin thioglycol monooctyl ester, 4 parts of deca-BDE, acetylene 0.5 part of carbon black, 8 parts of antimony oxide, 6 parts of land plaster, 5 parts of fergusonite powder, 1 part of kaolin, 4 parts of manganese naphthenate, ultraviolet light UV-P7 parts of absorbent, 0.5 part of antioxidant.
As a preferred technical solution of the present invention:The raw material of the preparation method of the medical non-toxic plastic presses mass parts Number proportioning is as follows:EBS100 parts, 5 parts of zinc oxide, 15 parts of calcined kaolin, 7 parts of Ag-carried nanometer titanium dioxide, chitosan graft first 25 parts of base methyl acrylate, 6 parts of cellulose acetate-butyrate, 20 parts of dioctyltin thioglycol monooctyl ester, 8 parts of deca-BDE, second 2.5 parts of alkynes carbon black, 10 parts of antimony oxide, 10 parts of land plaster, 9 parts of fergusonite powder, 3 parts of kaolin, 6 parts of manganese naphthenate are purple UV-P9 parts of ultraviolet absorbers, 4.5 parts of antioxidant.
As a preferred technical solution of the present invention:The raw material of the preparation method of the medical non-toxic plastic presses mass parts Number proportioning is as follows:EBS100 parts, 3 parts of zinc oxide, 10 parts of calcined kaolin, 5 parts of Ag-carried nanometer titanium dioxide, chitosan graft first 15 parts of base methyl acrylate, 4 parts of cellulose acetate-butyrate, 15 parts of dioctyltin thioglycol monooctyl ester, 6 parts of deca-BDE, second 1.5 parts of alkynes carbon black, 9 parts of antimony oxide, 8 parts of land plaster, 7 parts of fergusonite powder, 2 parts of kaolin, 5 parts of manganese naphthenate are ultraviolet UV-P8 parts of light absorbers, 2.5 parts of antioxidant.
As a preferred technical solution of the present invention:The antioxidant uses antioxidant 1076.
Advantageous effect
The preparation method of medical non-toxic plastic of the present invention a kind of using above technical scheme is compared with the prior art, have with Lower technique effect:1, applied widely, it is particularly suitable for joint prosthesis, every compound national standard of chemical property Testing index The requirement of GB15593-1995 and GB10010-88, product tensile strength longitudinal direction 40-50MPa, lateral 10-30MPa, hardness are good; 2, Escherichia coli antibiotic rate 99-99.5%, staphylococcus aureus antibiotic rate 98-99%, Pseudomonas aeruginosa bacteriostasis rate 99.5-99.9%, Salmonella typhimurium bacteriostasis rate 93-97%, Friedlander's bacillus bacteriostasis rate 92-96%, hay bacillus sterilization rate 94-98%, eight Folded coccus sterilization rate 91-95%;3, it does not degrade, printability resistance is good, no allergic reaction, to human body totally nontoxic, does not lead to inflammation Disease necrosis, preparation method is simple, and raw material is simple and easy to get, can extensively be produced in cleaning shop and constantly replace current material.
Specific implementation mode
Below in conjunction with example, the invention will be further described, and embodiment is only used for that the present invention will be described, not Constitute limitation to right, it may occur to persons skilled in the art that other alternative means, in right of the present invention In claimed range.
Embodiment 1:
The first step:EBS100 parts are weighed according to mass fraction proportioning, 1 part of zinc oxide, 5 parts of calcined kaolin, silver-carrying nano dioxy Change 3 parts of titanium, 5 parts of Graft Copolymerization of MMA onto Chitosan, 2 parts of cellulose acetate-butyrate, dioctyltin thioglycol monooctyl ester 10 Part, 4 parts of deca-BDE, 0.5 part of acetylene carbon black, 8 parts of antimony oxide, 6 parts of land plaster, 5 parts of fergusonite powder, kaolin 1 Part, 4 parts of manganese naphthenate, 7 parts of Ultraviolet Absorber UV-P, 0.5 part of antioxidant 1076 antioxidant.
Second step:EBS, zinc oxide, land plaster, fergusonite powder and manganese naphthenate are put into reaction kettle and are heated to 60 DEG C, stir 30min, 300 revs/min of mixing speed;
Third walks:Then add the remaining raw materials are warming up to 100 DEG C, stir 40min, 200 revs/min of mixing speed;
4th step:By mixed material put into extruder in, 180-190 DEG C of barrel temperature, 195-205 DEG C, 200-210 DEG C, 205-215 DEG C, 220-230 DEG C, 235-245 DEG C and 240-260 DEG C, screw rod 40-50mm, L/D 20-25, screw speed 60-80 Rev/min, squeeze out yield 30-40kg/h, 230-250 DEG C of head temperature.
It is applied widely, it is particularly suitable for joint prosthesis, every compound national standard of chemical property Testing index The requirement of GB15593-1995 and GB10010-88, product tensile strength longitudinal direction 40-50MPa, lateral 10-30MPa, hardness are good; Escherichia coli antibiotic rate 99-99.5%, staphylococcus aureus antibiotic rate 98-99%, Pseudomonas aeruginosa bacteriostasis rate 99.5-99.9%, mouse Salmonella typhi bacteriostasis rate 93-97%, Friedlander's bacillus bacteriostasis rate 92-96%, hay bacillus sterilization rate 94-98%, eight is folded Coccus sterilization rate 91-95%;It does not degrade, printability resistance is good, and no allergic reaction does not cause inflammation bad human body totally nontoxic Extremely, preparation method is simple, and raw material is simple and easy to get, can extensively be produced in cleaning shop and constantly replace current material.
Embodiment 2:
The first step:EBS100 parts are weighed according to mass fraction proportioning, 5 parts of zinc oxide, 15 parts of calcined kaolin, silver-carrying nano dioxy Change 7 parts of titanium, 25 parts of Graft Copolymerization of MMA onto Chitosan, 6 parts of cellulose acetate-butyrate, dioctyltin thioglycol monooctyl ester 20 Part, 8 parts of deca-BDE, 2.5 parts of acetylene carbon black, 10 parts of antimony oxide, 10 parts of land plaster, 9 parts of fergusonite powder, kaolin 3 parts, 6 parts of manganese naphthenate, 9 parts of Ultraviolet Absorber UV-P, 4.5 parts of antioxidant 1076 antioxidant.
Second step:EBS, zinc oxide, land plaster, fergusonite powder and manganese naphthenate are put into reaction kettle and are heated to 60- 80 DEG C, stir 30-50min, 300-500 revs/min of mixing speed;
Third walks:Then add the remaining raw materials are warming up to 100-120 DEG C, stir 40-60min, 200-600 revs/min of mixing speed Clock;
4th step:By mixed material put into extruder in, 180-190 DEG C of barrel temperature, 195-205 DEG C, 200-210 DEG C, 205-215 DEG C, 220-230 DEG C, 235-245 DEG C and 240-260 DEG C, screw rod 40-50mm, L/D 20-25, screw speed 60-80 Rev/min, squeeze out yield 30-40kg/h, 230-250 DEG C of head temperature.
It is applied widely, it is particularly suitable for joint prosthesis, every compound national standard of chemical property Testing index The requirement of GB15593-1995 and GB10010-88, product tensile strength longitudinal direction 40-50MPa, lateral 10-30MPa, hardness are good; Escherichia coli antibiotic rate 99-99.5%, staphylococcus aureus antibiotic rate 98-99%, Pseudomonas aeruginosa bacteriostasis rate 99.5-99.9%, mouse Salmonella typhi bacteriostasis rate 93-97%, Friedlander's bacillus bacteriostasis rate 92-96%, hay bacillus sterilization rate 94-98%, eight is folded Coccus sterilization rate 91-95%;It does not degrade, printability resistance is good, and no allergic reaction does not cause inflammation bad human body totally nontoxic Extremely, preparation method is simple, and raw material is simple and easy to get, can extensively be produced in cleaning shop and constantly replace current material.
Embodiment 3:
The first step:EBS100 parts are weighed according to mass fraction proportioning, 3 parts of zinc oxide, 10 parts of calcined kaolin, silver-carrying nano dioxy Change 5 parts of titanium, 15 parts of Graft Copolymerization of MMA onto Chitosan, 4 parts of cellulose acetate-butyrate, dioctyltin thioglycol monooctyl ester 15 Part, 6 parts of deca-BDE, 1.5 parts of acetylene carbon black, 9 parts of antimony oxide, 8 parts of land plaster, 7 parts of fergusonite powder, kaolin 2 Part, 5 parts of manganese naphthenate, 8 parts of Ultraviolet Absorber UV-P, 2.5 parts of antioxidant 1076 antioxidant.
Second step:EBS, zinc oxide, land plaster, fergusonite powder and manganese naphthenate are put into reaction kettle and are heated to 70 DEG C, stir 40min, 400 revs/min of mixing speed;
Third walks:Then add the remaining raw materials are warming up to 110 DEG C, stir 50min, 400 revs/min of mixing speed;
4th step:By mixed material put into extruder in, 180-190 DEG C of barrel temperature, 195-205 DEG C, 200-210 DEG C, 205-215 DEG C, 220-230 DEG C, 235-245 DEG C and 240-260 DEG C, screw rod 40-50mm, L/D 20-25, screw speed 60-80 Rev/min, squeeze out yield 30-40kg/h, 230-250 DEG C of head temperature.
It is applied widely, it is particularly suitable for joint prosthesis, every compound national standard of chemical property Testing index The requirement of GB15593-1995 and GB10010-88, product tensile strength longitudinal direction 50MPa, lateral 30MPa, hardness are good;Large intestine bar Bacterium antibiotic rate 99.5%, staphylococcus aureus antibiotic rate 99%, Pseudomonas aeruginosa bacteriostasis rate 99.9%, salmonella typhimurium is antibacterial Rate 97%, Friedlander's bacillus bacteriostasis rate 96%, hay bacillus sterilization rate 98%, sarcine sterilization rate 95%;It does not degrade, Printability resistance is good, no allergic reaction, to human body totally nontoxic, does not cause inflammation downright bad, preparation method is simple, and raw material is simply easy , it can extensively be produced in cleaning shop and constantly replace current material.
Composition all components in above example can be commercially available.
The above embodiments are merely intended to illustrate the present invention rather than to limit it, therefore with the present invention's Any change in the comparable meaning and scope of claims, should be construed as being included in the scope of the claims.

Claims (5)

1. a kind of preparation method of medical non-toxic plastic, which is characterized in that include the following steps:
The first step:EBS100 parts are weighed according to mass fraction proportioning, 5-15 parts of zinc oxide, 1-5 parts of calcined kaolin, silver-carrying nano 4-8 parts of titanium dioxide, 1-3 parts of Graft Copolymerization of MMA onto Chitosan, 2-4 parts of cellulose acetate-butyrate, dioctyltin sulphur 2-6 parts of glycol monooctyl ester, 3-5 parts of deca-BDE, 0.5-2.5 parts of acetylene carbon black, 8-10 parts of antimony oxide, 3-7 parts of land plaster, 4-6 parts of fergusonite powder, 5-9 parts of kaolin, 5-7 parts of manganese naphthenate, 0.5-1.5 parts of Ultraviolet Absorber UV-P, antioxidant 2.5-4.5 part;
Second step:EBS, zinc oxide, land plaster, fergusonite powder and manganese naphthenate are put into reaction kettle and are heated to 60-80 DEG C, Stir 30-50min, 300-500 revs/min of mixing speed;
Third walks:Then add the remaining raw materials are warming up to 100-120 DEG C, stir 40-60min, 200-600 revs/min of mixing speed Clock;
4th step:By mixed material put into extruder in, 180-190 DEG C of barrel temperature, 195-205 DEG C, 200-210 DEG C, 205-215 DEG C, 220-230 DEG C, 235-245 DEG C and 240-260 DEG C, screw rod 40-50mm, L/D 20-25, screw speed 60-80 Rev/min, squeeze out yield 30-40kg/h, 230-250 DEG C of head temperature.
2. a kind of preparation method of medical non-toxic plastic according to claim 1, which is characterized in that the medical poisonless modeling The raw material of the preparation method of material is matched as follows by mass fraction:EBS100 parts, 1 part of zinc oxide, 5 parts of calcined kaolin carries silver and receives 3 parts of titanium dioxide of rice, 5 parts of Graft Copolymerization of MMA onto Chitosan, 2 parts of cellulose acetate-butyrate, dioctyltin thioglycol 10 parts of monooctyl ester, 4 parts of deca-BDE, 0.5 part of acetylene carbon black, 8 parts of antimony oxide, 6 parts of land plaster, 5 parts of fergusonite powder are high 1 part of ridge soil, 4 parts of manganese naphthenate, 7 parts of Ultraviolet Absorber UV-P, 0.5 part of antioxidant.
3. a kind of preparation method of medical non-toxic plastic according to claim 1, which is characterized in that the medical poisonless modeling The raw material of the preparation method of material is matched as follows by mass fraction:EBS100 parts, 5 parts of zinc oxide, 15 parts of calcined kaolin carries silver and receives 7 parts of titanium dioxide of rice, 25 parts of Graft Copolymerization of MMA onto Chitosan, 6 parts of cellulose acetate-butyrate, dioctyltin thioglycol 20 parts of monooctyl ester, 8 parts of deca-BDE, 2.5 parts of acetylene carbon black, 10 parts of antimony oxide, 10 parts of land plaster, 9 parts of fergusonite powder, 3 parts of kaolin, 6 parts of manganese naphthenate, 9 parts of Ultraviolet Absorber UV-P, 4.5 parts of antioxidant.
4. a kind of preparation method of medical non-toxic plastic according to claim 1, it is characterised in that:The medical poisonless modeling The raw material of the preparation method of material is matched as follows by mass fraction:EBS100 parts, 3 parts of zinc oxide, 10 parts of calcined kaolin carries silver and receives 5 parts of titanium dioxide of rice, 15 parts of Graft Copolymerization of MMA onto Chitosan, 4 parts of cellulose acetate-butyrate, dioctyltin thioglycol 15 parts of monooctyl ester, 6 parts of deca-BDE, 1.5 parts of acetylene carbon black, 9 parts of antimony oxide, 8 parts of land plaster, 7 parts of fergusonite powder are high 2 parts of ridge soil, 5 parts of manganese naphthenate, 8 parts of Ultraviolet Absorber UV-P, 2.5 parts of antioxidant.
5. a kind of preparation method of medical non-toxic plastic according to claim 1, it is characterised in that:The antioxidant uses Antioxidant 1076.
CN201810546474.4A 2018-05-31 2018-05-31 A kind of preparation method of medical non-toxic plastic Withdrawn CN108676308A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810546474.4A CN108676308A (en) 2018-05-31 2018-05-31 A kind of preparation method of medical non-toxic plastic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810546474.4A CN108676308A (en) 2018-05-31 2018-05-31 A kind of preparation method of medical non-toxic plastic

Publications (1)

Publication Number Publication Date
CN108676308A true CN108676308A (en) 2018-10-19

Family

ID=63809286

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810546474.4A Withdrawn CN108676308A (en) 2018-05-31 2018-05-31 A kind of preparation method of medical non-toxic plastic

Country Status (1)

Country Link
CN (1) CN108676308A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024064816A1 (en) * 2022-09-23 2024-03-28 Eastman Chemical Company Cellulose ester mineral particle compositions and methods of reducing the molecular weight the cellulose ester in the compositions thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104479201A (en) * 2014-11-27 2015-04-01 苏州市贝克生物科技有限公司 Degradable medical film and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104479201A (en) * 2014-11-27 2015-04-01 苏州市贝克生物科技有限公司 Degradable medical film and preparation method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024064816A1 (en) * 2022-09-23 2024-03-28 Eastman Chemical Company Cellulose ester mineral particle compositions and methods of reducing the molecular weight the cellulose ester in the compositions thereof

Similar Documents

Publication Publication Date Title
CN105200856A (en) Chitosan/titanium dioxide nano-composite antibacterial coating preparation method
US3674901A (en) Surgical sutures
CN105218964B (en) Antibacterial polyvinyl chloride material and its preparation method and application
US20220354985A1 (en) Anti-Microbial Medical Materials and Devices
CN104387655A (en) Medical nano-zinc oxide antibacterial PE and preparation method thereof
CN102020790B (en) Natural polymer film material with adjustable degradation rate and preparation method
CN105327404B (en) A kind of TPE classes composition and high-performance medical catheter prepared therefrom
CN103627127A (en) High polymer elastomer material for balloon catheter type medical apparatuses and instruments and preparation method thereof
CN103602019B (en) A kind of novel method preparing high transparency plastics silver-containing inorganic antibacterial matrices on a large scale
CN108676308A (en) A kind of preparation method of medical non-toxic plastic
CN106566087A (en) Preparation method of base material for anion wall plates and floors capable of purifying indoor air
CN103665884A (en) Antibacterial nipple
CN104403229A (en) Medical antibacterial PVC(polyvinyl chloride) film and preparation method thereof
CN104387654A (en) Medical antibacterial HDPE and preparation method thereof
US20200270427A1 (en) Polyvinyl alcohol composition, preparation method thereof, and polyvinyl alcohol medical catheter containing thereof
CN104448556A (en) Medical silver-carrying antibacterial agent modified PP material and preparation method thereof
CN107868319A (en) A kind of cosmetic packaging soft tube of biodegradable antibacterial environment protection
CN104403231A (en) Medical packaging calendering film and preparation method thereof
CN104403169A (en) Medical LDPE(low-density polyethylene) antibacterial material and preparation method thereof
CN108659330A (en) A kind of plastics and preparation method thereof with antibacterial functions
CN104387669A (en) Medical PP inorganic antibacterial composite and preparation method thereof
CN104448677A (en) Medical antibacterial ABS material and preparation method thereof
CN115058076B (en) Antibacterial and antioxidant color master batch, plastic bottle and preparation methods thereof
CN114891290B (en) Antibacterial polyethylene wear-resistant boot sleeve
CN101451011A (en) Polyolefin thermoplastic elastomer blending resin and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20181019